Date on Senior Honors Thesis
5-2025
Document Type
Senior Honors Thesis
Degree Name
B.S.
Department
Chemistry
Author's Keywords
breast cancer; sage; phytochemical; antiproliferation
Abstract
Breast cancer is the most common cancer diagnosed in female adults, with 2.3 million new cases worldwide in 2020. Plants have been used in traditional medicine and are a potential source of pharmaceuticals. One example is the large Lamiaceae (mint) family. The Salvia genus, commonly known as the sages, is the largest genus in Lamiaceae with almost 900 known species. Salvia lyrata (lyre-leaved sage) has a history of Native American medicinal use to treat cancers and other ailments resulting in this plant being referred to as ‘cancer weed.’ Extracts were produced from the leaves of S. lyrata, S. lyrata ‘Purple Knockout,’ and Salvia officinalis (common sage, a naturalized European plant) and assessed for phytochemical content. All extracts were then assessed for ability to limit proliferation in three breast cancer cell lines (MDA-MB-231, BT474, and T47D). Extracts of S. officinalis had the greatest impact on cell proliferation when compared to both S. lyrata extracts. To expand upon these findings, acid hydrolysis was employed to remove glycosides and thus influence extract polarity to increase antiproliferation activity. Acid hydrolysis increased the anticancer activity of S. officinalis in the T-47D cell line. Luteolin and apigenin were identified in extracts and were tested for antiproliferative activity and found to have the greatest activity of the phenolic compounds tested against the MDA-MB-231 and T-47D cell lines. Finally, to test for possible mechanism of action, an apoptosis assay and qRT-PCR assay were employed to evaluate apoptosis as a mechanism of antiproliferative activity against MDA-MB-231 cell line with S. officinalis extracts.
Recommended Citation
Portaro, Allison C., "Antiproliferative effects of Salvia on breast cancers." (2025). College of Arts & Sciences Senior Theses. Paper 333.
Retrieved from https://ir.library.louisville.edu/honors/333
Lay Summary
This study explores how chemicals naturally produced in plants may be used in treatment for breast cancers. Breast cancer is the most common cancer diagnosed in female adults, which makes treatment research an area of great importance. Plants have been used in traditional medicine and are a potential source of pharmaceuticals. One example is the mint family, which includes the herb known as sage. Three varieties of sage were collected and used as sources for extracting and then testing effects of plant chemicals. Extracts were analyzed, and chemicals in the extracts were identified. The extracts were then tested as treatments against three different breast cancer types to evaluate if they result in a reduction of cancer cell growth (proliferation). An extract of culinary sage was found to have the greatest impact in reducing cancer cell growth, and importantly, was the most effective against the most aggressive form of breast cancer tested.
Further studies were conducted to investigate the means by which the extracts impact cell proliferation. Specifically, the extracts were tested for an ability to affect the cells’ normal death process. In cancer cells, the normal death process is often altered and is part of the reason the cells are cancerous. Results did not indicate that cell death was the main mechanism of inhibition observed for the extracts, and thus further studies are needed to understand how these extracts work to limit cancer growth.
Included in
Biochemistry Commons, Chemicals and Drugs Commons, Medicinal-Pharmaceutical Chemistry Commons